The objective of this study was to investigate the contribution of the tumor necrosis factor-α (TNF-α) gene polymorphisms to recurrent spontaneous abortion (RSA). The study participants consisted of 357 Korean women with RSA and 236 fertile women controls. Four TNF-α gene variants of all participants were analyzed by polymerase chain reaction–restriction fragment length polymorphism assay. The TNF-α -1031T>C and TNF-α -238G>A variants increased the risk of RSA TNF-α -1031TC+CC; adjusted odds ratio [AOR], 2.292; 95% confidence interval [CI], 1.547-3.395; P < .001; TNF-α -238GA+AA; AOR, 2.327; 95% CI, 1.038-5.217; P = .040), and these data were not different in a stratified analysis according to the number of consecutive spontaneous abortions. Also, the mutant genotypes of TNF-α -1031 and TNF-α -238 showed synergistic effects on increased RSA risk (-1031TC+CC/-238GA+AA; AOR, 4.054; 95% CI, 1.520-10.812; P = .005). In haplotype analysis, there were similar trends of data for combination analysis. In conclusion, the TNF-α -1031T>C and TNF-α -238G>A variants are possible genetic risk factors for RSA.
SierraSStephensonM. Genetics of recurrent pregnancy loss. Semin Reprod Med. 2006;24(1):17–24.
2.
WilcoxAJWeinbergCRO'ConnorJFIncidence of early loss of pregnancy. N Engl J Med. 1988;319(4):189–194.
3.
LiuCWangJZhouSWangBMaX. Association between -238 but not -308 polymorphism of tumor necrosis factor alpha (TNF-alpha)v and unexplained recurrent spontaneous abortion (URSA) in Chinese population. Reprod Biol Endocrinol. 2010;8:114.
4.
MakhseedMRaghupathyRAziziehFOmuAAl-ShamaliEAshkananiL. TH1 and TH2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod. 2001;16(10):2219–2226.
5.
WegmannTGLinHGuilbertLMosmonnTR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon. Immunol Today. 1993;14(7):353–356.
6.
ZhuXYZhouYHWangMYJinLPYuanMMLiDJ. Blockade of CD86 signaling facilitates a TH2 bias at the maternal-fetal interface and expands peripheral CD4þCD25þ regulatory T cells to rescue abortion-prone fetuses. Biol Reprod. 2005;72(2):338–345.
7.
ReidJGSimpsonNAWalkerRGThe carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol. 2001;45(1):35–40.
8.
HillJAPolgarKAndersonDJ. T-Helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA. 1995;273(24):1933–1936.
9.
HehlgansTPfefferK. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology. 2005;115(1):1–20.
RezaeiADabbaghA.T-Helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit. 2002;8(8):CR607–CR610.
12.
Garcia-LloretMIWinkler-LowenBGuilbertLJ. Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-a. A model for hematogenous initiation of placental inflammations. J Leukoc Biol. 2000;68(6):903–908.
13.
Kwak-KimJYGilman-SachsAKimCE. T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy. 2005;88:64–79.
14.
FortunatoSJMenonRLombardiSJ. Support for an infection induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol. 2001;184(7):1392–1398.
15.
RaghupathyRMakhseedMAziziehFOmuAGuptaMFarhatR. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod. 2000;15(3):713–718.
16.
HannaJGoldman-WohlDHamaniYDecidual NK cells regulate key developmental processes at the human fetal–maternal interface. Nat Med. 2006;12(9):1065–1074.
17.
MorganGJAdamsonPJMensahFKHaplotypes in the tumour necrosis factor region and myeloma. Br J Haematol. 2005;129(3):358–365.
18.
ReichKHüffmeierUKönigIRTNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis Rheum. 2007;56(6):2056–2064.
19.
HuizingaTWWestendorpRGBollenELTNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997;72(2):149–153.
20.
DaherSShulzhenkoNMorgunAAssociations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol. 2003;58(1):69–77.
21.
KopreskiMSLiptonAHarveyHAKumarR. Growth inhibition of breast cancer cell lines by combinations of anti-P185HER2 monoclonal antibody and cytokines. Anticancer Res. 1996;16(1):433–436.
22.
PagliacciMCFumiGMiglioratiGGrignaniFRiccardiCNicolettiI. Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones. Lymphokine Cytokine Res. 1993;12(6):439–447.
23.
CaiZStancouRKornerMShouaibS. Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int J Cancer. 1996;68(4):535–546.
24.
HagiharaMShimuraTSatoKGengaKSuzukiMTsujiK. HLA and tumor necrosis factor beta gene polymorphisms in Okinawa lung cancer patients: comparative study with mainland Japan lung cancer patients. Hum Immunol. 1995;43(2):95–100.
25.
MesserGSpenglerUJungMCPolymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991;173(1):209–219.
26.
OzakiKOhnishiYIidaAFunctional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32(4):650–654.
27.
HiguchiTSekiNKamizonoSPolymorphism of the 5’-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51(6):605–612.
28.
SogaYNishimuraFOhyamaHMaedaHTakashibaSMurayamaY. Tumor necrosis factor-alpha gene (TNF-alpha)-1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol. 2003;30(6):524–531.
29.
PrigoshinNTambuttiMLarribaJGogorzaSTestaR. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol. 2004;52(1):36–41.
30.
BaxterNSumiyaMChengSRecurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin-a genes. Clin Exp Immunol. 2001;126(3):529–534.
31.
Kamali-SarvestaniEZolghadriJGharesi-FardBSarvariJ. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol. 2005;65(2):171–178.
32.
ZammitiWMtiraouiNFinanRRAlmawiWYMahjoubT. Tumor necrosis factor α and lymphotoxin a haplotypes in idiopathic recurrent pregnancy loss. Fertil Steril. 2009;91(5):1903–1908.
33.
RaghupathyR. TH1-type immunity is incompatible with successful pregnancy. Immunol Today. 1997;18(10):478–482.
34.
AokiKKajiuraSMatsumotoYPreconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet. 1995;345(8961):1340–1342.
35.
YamadaHKatoEHKobashiGHigh NK cell activity in early pregnancy correlates with subsequent abortion with normal chromosomes in women with recurrent abortion. Am J Reprod Immunol. 2001;46(2):132–136.
36.
BorzychowskiAMCroyBAChanWLRedmanCWSargentIL. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol. 2005;35(10):3054–3063.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
